Development and preclinical evaluation of a pan-coronavirus mRNA vaccine targeting conserved spike protein epitopes, demonstrating broad neutralizing antibody responses against SARS-CoV-2 variants and related coronaviruses.
Keywords: mRNA Vaccine, Coronavirus, Preclinical Study, Neutralizing Antibodies, Pan-Coronavirus